BioRestorative Therapies (BRTX) Competitors $1.48 +0.03 (+2.07%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BRTX vs. CCM, MRAI, OPGN, PMD, TOI, OTRK, ATIP, MGRX, ATPC, and KDLYShould you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include Concord Medical Services (CCM), Marpai (MRAI), OpGen (OPGN), Psychemedics (PMD), Oncology Institute (TOI), Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), Agape ATP (ATPC), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. BioRestorative Therapies vs. Concord Medical Services Marpai OpGen Psychemedics Oncology Institute Ontrak ATI Physical Therapy Mangoceuticals Agape ATP Kindly MD Concord Medical Services (NYSE:CCM) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, community ranking, earnings and institutional ownership. Which has stronger valuation & earnings, CCM or BRTX? BioRestorative Therapies has lower revenue, but higher earnings than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$471.70M0.04-$41.93MN/AN/ABioRestorative Therapies$377K27.17-$14.41M-$1.53-0.97 Does the MarketBeat Community favor CCM or BRTX? Concord Medical Services received 195 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 62.54% of users gave Concord Medical Services an outperform vote. CompanyUnderperformOutperformConcord Medical ServicesOutperform Votes19762.54% Underperform Votes11837.46% BioRestorative TherapiesOutperform Votes2100.00% Underperform VotesNo Votes Is CCM or BRTX more profitable? Concord Medical Services has a net margin of 0.00% compared to BioRestorative Therapies' net margin of -2,697.08%. Concord Medical Services' return on equity of 0.00% beat BioRestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A BioRestorative Therapies -2,697.08%-98.49%-75.23% Which has more risk & volatility, CCM or BRTX? Concord Medical Services has a beta of -0.27, indicating that its share price is 127% less volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 63.4, indicating that its share price is 6,240% more volatile than the S&P 500. Do institutionals & insiders have more ownership in CCM or BRTX? 69.4% of BioRestorative Therapies shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by insiders. Comparatively, 25.5% of BioRestorative Therapies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor CCM or BRTX? In the previous week, BioRestorative Therapies had 6 more articles in the media than Concord Medical Services. MarketBeat recorded 7 mentions for BioRestorative Therapies and 1 mentions for Concord Medical Services. BioRestorative Therapies' average media sentiment score of 0.09 beat Concord Medical Services' score of 0.00 indicating that BioRestorative Therapies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Concord Medical Services 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioRestorative Therapies 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate CCM or BRTX? BioRestorative Therapies has a consensus price target of $18.00, suggesting a potential upside of 1,116.22%. Given BioRestorative Therapies' stronger consensus rating and higher probable upside, analysts plainly believe BioRestorative Therapies is more favorable than Concord Medical Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Concord Medical Services 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BioRestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryBioRestorative Therapies beats Concord Medical Services on 10 of the 16 factors compared between the two stocks. Ad Brownstone ResearchMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. Get BioRestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRTX vs. The Competition Export to ExcelMetricBioRestorative Therapieshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.24M$2.07B$5.38B$8.84BDividend YieldN/A7.23%5.13%4.09%P/E Ratio-0.9716.00105.1417.83Price / Sales27.173.291,233.15158.41Price / CashN/A10.1340.4136.29Price / Book1.033.897.096.50Net Income-$14.41M$69.56M$119.65M$226.22M7 Day Performance2.07%0.89%2.25%4.03%1 Month Performance-7.50%6.58%-2.33%4.92%1 Year Performance-20.43%-20.83%33.98%29.30% BioRestorative Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRTXBioRestorative Therapies3.4739 of 5 stars$1.48+2.1%$18.00+1,116.2%-20.4%$10.24M$377,000.00-0.977Gap UpCCMConcord Medical Services0.341 of 5 stars$4.45+6.0%N/A-56.0%$18.24M$471.70M0.00970MRAIMarpai2.0668 of 5 stars$1.21-26.2%$6.00+395.9%-31.7%$16.63M$37.15M-0.62150Gap UpOPGNOpGenN/A$1.81-9.0%N/A-63.9%$15.13M$3.42M0.00100Gap DownPMDPsychemedics0.8408 of 5 stars$2.34flatN/A+12.0%$13.78M$22.10M-4.57140TOIOncology Institute2.2827 of 5 stars$0.16+14.8%$2.50+1,512.9%-92.3%$11.70M$324.24M-0.20660Gap UpHigh Trading VolumeOTRKOntrak2.7403 of 5 stars$1.83flat$45.00+2,359.0%-78.7%$7.72M$12.74M-0.17250Negative NewsATIPATI Physical Therapy0.2334 of 5 stars$1.47-7.5%N/A-75.4%$6.48M$699.02M-0.085,600High Trading VolumeMGRXMangoceuticals0.4525 of 5 stars$2.50+1.2%N/A-97.8%$6.23M$730,000.00-0.433Gap DownATPCAgape ATP0.0125 of 5 stars$1.52+5.6%N/A-93.9%$6.07M$1.43M-2.0840KDLYKindly MD0.1695 of 5 stars$0.97+6.6%N/AN/A$5.80MN/A0.00N/ALockup ExpirationGap Up Related Companies and Tools Related Companies Concord Medical Services Competitors Marpai Competitors OpGen Competitors Psychemedics Competitors Oncology Institute Competitors Ontrak Competitors ATI Physical Therapy Competitors Mangoceuticals Competitors Agape ATP Competitors Kindly MD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BRTX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.